Evidence map›Paper›PMID 30209264›Full record

ArticleNature communications2018

Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.

Doan C Nguyen, Swetha Garimalla, Haopeng Xiao, Shuya Kyu, Igor Albizua, Jacques Galipeau, Kuang-Yueh Chiang, Edmund K Waller, Ronghu Wu, Greg Gibson and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Why are long-lived plasma cells long-lived?Frontiers in immunology · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Doan C NguyenDivision of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-5389-6731
Swetha GarimallaSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
Haopeng XiaoSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-4166-647X
Shuya KyuDivision of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University, Atlanta, GA, USA.
Igor AlbizuaDepartment of Human Genetics, Emory University, Atlanta, GA, USA.
Jacques GalipeauDepartment of Medicine & University of Wisconsin Carbone Cancer Center, University of Wisconsin in Madison, Madison, WI, USA.
Kuang-Yueh ChiangDivision of Hematology & Oncology, University of Toronto, Toronto, ON, Canada.
Edmund K WallerPediatrics & Hematology/Oncology, Emory University, Atlanta, GA, USA.
Ronghu WuSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-9493-9462
Greg GibsonSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-5352-5877
James RobersonDepartment of Orthopedics, Emory University, Atlanta, GA, USA.
Frances E LundDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Troy D RandallDivision of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Iñaki SanzDivision of Rheumatology, Emory University, Atlanta, GA, USA.
F Eun-Hyung LeeDivision of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University, Atlanta, GA, USA. f.e.lee@emory.edu.
Emory University · USGeorgia Institute of Technology · USUniversity of Alabama at Birmingham · USEmory Healthcare · USUniversity of Toronto · CAUniversity of Wisconsin Carbone Cancer Center · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Regulation of Pathogenic Plasma Cells in Human SLEP01AI125180 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2016 to 2026
$28.2M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Virus-induced Cell Fate Decisions in Anti-Viral ImmunityU19AI109962 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2014 to 2018
$11.6M
Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI LOONEY, RICHARD JOHN · 2010 to 2014
$10.8M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
Understanding Survival of Human Bone Marrow Long-Lived Plasma CellsR01AI121252 · NIAID · EMORY UNIVERSITY · PI LEE, FRANCES EUN-HYUNG · 2016 to 2020
$2.7M
Pathogenesis of RSV disease in the ElderlyU01AI045969 · NIAID · UNIVERSITY OF ROCHESTER · PI WALSH, EDWARD E · 2004 to 2008
$2.5M
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis.R01DK109508 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI GALIPEAU, JACQUES · 2016 to 2019
$2.1M
Characterization of a Novel Diagnostic Test for Pneumococcal InfectionR21AI094218 · NIAID · EMORY UNIVERSITY · PI LEE, FRANCES EUN-HYUNG · 2012 to 2013
$440k
Human IgE Antibody Secreting Cells in Blood, Nasal Polyps, and Bone MarrowR21AI109601 · NIAID · EMORY UNIVERSITY · PI LEE, FRANCES EUN-HYUNG · 2014 to 2015
$429k
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050029N01AI050029 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2006 to 2006
–
NCATS NIH HHS UL1 TR000454NCI NIH HHS P30 CA013148NIAID NIH HHS HHSN266200500030CNIAID NIH HHS N01 AI050029NIAID NIH HHS P01 AI078907NIAID NIH HHS P01 AI125180NIAID NIH HHS R01 AI121252NIAID NIH HHS R21 AI109601NIAID NIH HHS R37 AI049660NIAID NIH HHS U01 AI045969NIAID NIH HHS U19 AI109962NIDDK NIH HHS R01 DK109508
6 · The paper itself

Abstract

Human antibody-secreting cells (ASC) in peripheral blood are found after vaccination or infection but rapidly apoptose unless they migrate to the bone marrow (BM). Yet, elements of the BM microenvironment required to sustain long-lived plasma cells (LLPC) remain elusive. Here, we identify BM factors that maintain human ASC > 50 days in vitro. The critical components of the cell-free in vitro BM mimic consist of products from primary BM mesenchymal stromal cells (MSC), a proliferation-inducing ligand (APRIL), and hypoxic conditions. Comparative analysis of protein-protein interactions between BM-MSC proteomics with differential RNA transcriptomics of blood ASC and BM LLPC identify two major survival factors, fibronectin and YWHAZ. The MSC secretome proteins and hypoxic conditions play a role in LLPC survival utilizing mechanisms that downregulate mTORC1 signaling and upregulate hypoxia signatures. In summary, we identify elements of the BM survival niche critical for maturation of blood ASC to BM LLPC.

Indexed as

14-3-3 ProteinsAdultAntibody-Producing CellsBone MarrowCells, CulturedCell SurvivalFemaleFibronectinsHumansMaleMesenchymal Stem CellsMiddle AgedProtein BindingTumor Necrosis Factor Ligand Superfamily Member 13Young Adult14-3-3 ProteinsFibronectinsTumor Necrosis Factor Ligand Superfamily Member 13YWHAZ protein, human

Identifiers

PMID30209264
PMCPMC6135805
OpenAlexW2891470462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.